Jason Wittes
Stock Analyst at Roth MKM
(3.14)
# 962
Out of 4,415 analysts
40
Total ratings
45.45%
Success rate
2.1%
Average return
Main Sectors:
16 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $348 → $405 | $326.63 | +23.99% | 9 | May 1, 2024 | |
| IRMD IRadimed | Reinstates: Buy | $65 | $43.85 | +48.23% | 1 | Apr 22, 2024 | |
| FBIO Fortress Biotech | Reinstates: Buy | $10 | $1.80 | +455.56% | 1 | Mar 15, 2024 | |
| OFIX Orthofix Medical | Maintains: Neutral | $12 → $15 | $13.24 | +13.29% | 2 | Mar 7, 2024 | |
| STXS Stereotaxis | Reiterates: Buy | $5 | $2.32 | +115.52% | 4 | Mar 5, 2024 | |
| ARAY Accuray | Initiates: Buy | $9 | $1.54 | +484.42% | 2 | Feb 13, 2024 | |
| ENOV Enovis | Initiates: Buy | $75 | $52.13 | +43.87% | 2 | Oct 20, 2023 | |
| ATEC Alphatec Holdings | Initiates: Buy | $22 | $13.21 | +66.54% | 2 | Oct 20, 2023 | |
| ZBH Zimmer Biomet Holdings | Initiates: Neutral | $120 | $118.46 | +1.30% | 6 | Oct 20, 2023 | |
| GMED Globus Medical | Initiates: Buy | $75 | $50.48 | +48.57% | 2 | Oct 20, 2023 | |
| MASI Masimo | Initiates: Buy | $206 | $136.25 | +51.19% | 1 | Sep 14, 2022 | |
| DRI Darden Restaurants | Reinstates: Buy | $145 | $147.86 | -1.93% | 1 | Jun 27, 2022 | |
| BWAY BrainsWay | Initiates: Buy | $15 | $5.82 | +157.73% | 2 | Mar 3, 2022 | |
| NVCR NovoCure | Initiates: Buy | $200 | $14.19 | +1,309.44% | 3 | Feb 8, 2022 | |
| BTCY Biotricity | Initiates: Outperform | n/a | $1.30 | - | 1 | Jul 1, 2021 | |
| TGTX TG Therapeutics | Initiates: Buy | n/a | $16.42 | - | 1 | Feb 22, 2017 |
Stryker
May 1, 2024
Maintains: Buy
Price Target: $348 → $405
Current: $326.63
Upside: +23.99%
IRadimed
Apr 22, 2024
Reinstates: Buy
Price Target: $65
Current: $43.85
Upside: +48.23%
Fortress Biotech
Mar 15, 2024
Reinstates: Buy
Price Target: $10
Current: $1.80
Upside: +455.56%
Orthofix Medical
Mar 7, 2024
Maintains: Neutral
Price Target: $12 → $15
Current: $13.24
Upside: +13.29%
Stereotaxis
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.32
Upside: +115.52%
Accuray
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.54
Upside: +484.42%
Enovis
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $52.13
Upside: +43.87%
Alphatec Holdings
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $13.21
Upside: +66.54%
Zimmer Biomet Holdings
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $118.46
Upside: +1.30%
Globus Medical
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $50.48
Upside: +48.57%
Masimo
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $136.25
Upside: +51.19%
Darden Restaurants
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $147.86
Upside: -1.93%
BrainsWay
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $5.82
Upside: +157.73%
NovoCure
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $14.19
Upside: +1,309.44%
Biotricity
Jul 1, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.30
Upside: -
TG Therapeutics
Feb 22, 2017
Initiates: Buy
Price Target: n/a
Current: $16.42
Upside: -